Loading clinical trials...

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04649580

United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting

The aim of the study is to generate real-world evidence to describe the patient experience of administration of Somatuline® Autogel® (lanreotide) in homecare and hospital settings, and the associated ...

Lead sponsor: Ipsen•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment80

Start dateApr 2021

Last updatedDec 17, 2024

Condition

Neuroendocrine Tumours (NET)

Locations shown

University Hospitals Birmingham NHS Foundation Trust

Birmingham

Cardiff and Vale University LHB

Cardiff

University Hospitals Coventry and Warwickshire NHS Trust

Coventry

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 17, 2024Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions